Transfer-pricing comparability and corroborative evidence limit adjustments, while related tax, incentive and deduction issues receive distinct treatment.
Sales-promotion expenditure is distinguished between legitimate business-promotion activities and prohibited travel or hotel benefits directly provided to medical practitioners. The notes address the need for corroborative evidence before sustaining search-based allegations of inflated purchases, and treat manufacturing scrap and empty-container receipts as linked to eligible industrial operations. They describe excise-duty refunds under an industrialisation incentive scheme as capital in nature, and examine transfer-pricing adjustments through functional comparability, reliable market adjustments and evidence of services rendered. They also cover interest-free funds and exempt-income investments under section 14A, foreign tax credit ceilings, and verification of in-house research expenditure. The stated ratio requires reliable comparability or corroborative evidence for transfer-pricing and search-based additions.
Issues: (i) Allowability of sales-promotion expenditure allegedly constituting prohibited freebies to medical practitioners; (ii) validity of additions for alleged over-invoicing of raw-material purchases; (iii) eligibility of scrap and empty-container receipts for profit-linked deductions; (iv) character and tax treatment of excise-duty refund under the NEIIPP Scheme; (v) transfer-pricing adjustments relating to transactions with Exon Laboratories, inter-unit transfers, Nigerian exports, corporate guarantee and United States support services; (vi) disallowance under section 14A and its treatment under section 115JB; (vii) foreign tax credit for Colombian taxes; and (viii) deduction for in-house research and development expenditure.
Issue (i): Allowability of sales-promotion expenditure allegedly constituting prohibited freebies to medical practitioners.
Analysis: Explanation 1 to section 37(1), read with Regulation 6.8.1 of the Medical Council of India Regulations and CBDT Circular No. 5/2012, disallows expenditure that directly confers prohibited gifts, travel facilities, hospitality or monetary benefits on medical practitioners. Applying the binding earlier order in the assessee's own case, expenditure on conferences, awareness programmes, camps, exhibitions, sponsorships, journals, field printing, taxi charges and nominal brand-recall items was treated as legitimate business-promotion expenditure. Travel and hotel expenditure directly benefiting doctors remained prohibited.
Conclusion: The restricted disallowance of travel and hotel facilities provided to doctors was sustained; the remaining sales-promotion expenditure was allowable. The conclusion is partly against the assessee and partly in favour of the assessee.
Issue (ii): Validity of additions for alleged over-invoicing of raw-material purchases.
Analysis: The addition rested substantially on search statements that were retracted and on allegations concerning transactions involving a group concern and another supplier from whom the assessee had made no purchases. The cash found during search had been assessed in the individual hands of its possessor. No incriminating material, supplier confirmation, or independent evidence established inflated purchases or cash being received back by the assessee.
Conclusion: The additions for alleged over-invoicing were unsustainable and were deleted. The conclusion is in favour of the assessee.
Issue (iii): Eligibility of scrap and empty-container receipts for profit-linked deductions.
Analysis: Receipts from sale of scrap and empty containers generated in the manufacturing process were directly attributable to the operations of the eligible industrial undertakings. The Revenue identified no factual or legal distinction from the earlier orders allowing such claims.
Conclusion: Profits from sale of manufacturing scrap and empty containers qualify for deductions under sections 80-IB, 80-IC and 80-IE. The conclusion is in favour of the assessee.
Issue (iv): Character and tax treatment of excise-duty refund under the NEIIPP Scheme.
Analysis: The incentive scheme was intended to induce establishment of industries and employment generation in the economically underdeveloped North-Eastern region. Applying the purpose test, the refund was linked to industrialisation rather than the assessee's ordinary trading operations. The appellate authority could admit the claim made through a revised computation. A capital receipt outside taxable income could not be included in book profit under section 115JB.
Conclusion: The excise-duty refund was a non-taxable capital receipt and was excludible from both normal taxable income and book profit. The conclusion is in favour of the assessee.
Issue (v): Transfer-pricing adjustments relating to transactions with Exon Laboratories, inter-unit transfers, Nigerian exports, corporate guarantee and United States support services.
Analysis: For purchases and job-work transactions with Exon Laboratories, the comparables selected by the Transfer Pricing Officer were functionally dissimilar finished-product manufacturers and lacked a proper functional, asset and risk analysis; entity-level TNMM adopted by the assessee was upheld. For inter-unit transfers, monthly CUP comparisons were held more reliable than annual weighted averages, while the statutory 3% tolerance range under Rule 10CA was correctly allowed. For exports to Nigeria, uncontrolled sales in geographically and economically dissimilar markets could not support CUP without reliable adjustments; entity-level TNMM was appropriate. Actual bank guarantee charges already offered by the assessee adequately benchmarked the corporate guarantee. Genuine United States marketing, regulatory and liaisoning services could not be assigned a nil value without contrary comparables or evidence that services were not rendered.
Conclusion: Adjustments concerning Exon Laboratories, Nigerian exports, corporate guarantee and United States support services were deleted; the adjustment for inter-unit transfers, as restricted by the Commissioner (Appeals) after Rule 10CA relief, was sustained. The conclusion is partly in favour of the assessee and partly against the assessee.
Issue (vi): Disallowance under section 14A and its treatment under section 115JB.
Analysis: The assessee's own interest-free funds exceeded investments yielding exempt income, and no nexus between borrowings and such investments was established. For administrative expenditure, only investments that actually yielded exempt income could be considered. The disallowance computed under section 14A read with Rule 8D could not be mechanically added while computing book profit under section 115JB.
Conclusion: No further disallowance beyond the assessee's voluntary disallowance survived, and no section 14A adjustment was permissible in book-profit computation. The conclusion is in favour of the assessee.
Issue (vii): Foreign tax credit for Colombian taxes.
Analysis: The assessee produced additional certified income-and-expenditure material relevant to determining profits actually attributable to Colombian operations. Such material was material to the ceiling on foreign tax credit under sections 90 and 91 read with Rule 128.
Conclusion: The foreign-tax-credit claim was remanded to the Assessing Officer for fresh determination after considering the additional evidence. The conclusion is neutral.
Issue (viii): Deduction for in-house research and development expenditure.
Analysis: For the assessment year preceding the operative effect of the amendment requiring quantification by the prescribed authority, the amount recorded in Form 3CL was not by itself determinative of deduction under section 35(2AB). However, the remaining research expenditure had not been independently examined for its nature, evidentiary support and nexus with approved scientific research.
Conclusion: The claim for the balance research and development expenditure was remanded to the Assessing Officer for independent verification and fresh adjudication. The conclusion is neutral.
Final Conclusion: The Revenue's challenges to relief granted on the principal additions and most transfer-pricing issues fail, while the assessee obtains relief on several substantive issues; limited transfer-pricing disallowance remains and the foreign-tax-credit and research-deduction claims require fresh adjudication.
Ratio Decidendi: A transfer-pricing adjustment or search-based addition must rest on reliable comparability or corroborative evidence; retracted statements, functionally incomparable benchmarks and unadjusted cross-market price comparisons cannot independently sustain an addition.